Fair Richard A. 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Aug 16, 2022
Insider Transaction Report
Form 4
Fair Richard A.
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2022-08-15$1.44/sh+400,000$576,000→ 400,000 totalExercise: $1.44Exp: 2032-08-15→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]One-third (1/3rd) of the shares subject to the option will vest on the one-year anniversary on August 16, 2023, and the remaining shares will vest in twenty-four (24) equal monthly installments thereafter.